The Society's three strategic priorities are to promote the study and acceptance of gender based biology in the scientific community; to enhance the recruitment and retention of women in clinical trials; and to increase research funding for women's health research. 

REAST CANCER, CERVICAL CANCER, CLINICAL TRIALS, EATING DISORDERS, GENDER AND GENDER BIAS/GENDER DIFFERENCES, LUNG CANCER, MENOPAUSE, MENTAL HEALTH, OSTEOPOROSIS, OVARIAN CANCER, RESEARCH, UTERINE CANCER, VAGINAL CANCER, VIOLENCE, AIDS/ACQUIRED IMMUNODEFICIENCY SYNDROME, CARDIOVASCULAR DISEASES AND DISORDERS, HIV / HUMAN IMMUNODEFICIENCY VIRUS, SEXUALLY TRANSMITTED DISEASES/STDS, ADVOCACY/ADVOCACY SERVICES, PREMENSTRUAL DYSPHORIC DISORDER (PMDD)